Department of Chemistry & Chemical Biology Rutgers, the State University of New Jersey
Professor Joachim Kohn is the Board of Governors Professor of Chemistry at Rutgers University. He also serves as the Director of the Rutgers-Cleveland Clinic Consortium of the Armed Forces Institute of Regenerative Medicine (AFIRM). He has served as Director of the New Jersey Center for Biomaterials since its establishment in 1997. He is a Fellow of the American Institute for Medical and Biological Engineering (AIMBE) and the Chair of the International College of Fellows of Biomaterials Science and Engineering (IUSBSE). He is the principal investigator of several leading federally-funded R&D programs such as the NIH-funded postdoctoral training program in Tissue Engineering, the NSF-funded Partnership for Innovation designed to explore new plant-synthetic hybrid biomaterials, and the NIH funded National Resource for Polymeric Biomaterials (RESBIO).
Professor Kohn's research interests focus on the development of new biomaterials for use in regenerative medicine. He pioneered the use of combinatorial and computational methods for the optimization of biomaterials for specific medical applications. He is mostly known for his seminal work on tyrosine-derived biomaterials – a new class of polymers that combine the non-toxicity of individual amino acids with the strength and process ability of high-quality engineering plastics. He has contributed to the development of several new medical implants. He has published over 200 scientific manuscripts and reviews and holds about 40 issued US patents.
Since 1997, Professor Kohn has received over $75 Million in research support from US government agencies, the New Jersey state government, and private corporations and foundations. He has gained extensive technology transfer experience. He is the scientific founder of three spin-off companies (VectraMed, TyRx Pharma, Trident Biomedical), and serves on the scientific advisory board of several other companies. Innovative medical products using Kohn’s tyrosine-derived biomaterials are already in routine clinical use. In 2008, Kohn testified before Subcommittee on Health of the Committee on Energy and Commerce on “Treatments for an Ailing Economy: Protecting Health Care Coverage and Investing in Biomedical Research.”
In 2007, Professor Kohn was inducted into the New Jersey High-Tech Hall of Fame. He is the recipient of numerous awards and honors, including the prestigious Thomas Alva Edison Patent Award for best patent in New Jersey in the category of medical research, once in 1999 for his invention of tyrosine-derived polycarbonates, and once in 2006 for his invention of the first combinatorially designed library of polyarylates. His other awards include the 2003 Clemson Award for Basic Science of the Society for Biomaterials, a 1997 Special Opportunity Award of the Whitaker Foundation, a 1993 Hoechst-Celanese Innovative Research Award, a 1992 Young Investigator Research Achievement Award of the Controlled Release Society, a 1992 Board of Trustees Research Fellowship for Scholarly Excellence at Rutgers University, and a 1990 NIH Research Career Development Award.